Purchase Order W81K0021P0318
Award Date
10/1/21
Potential Completion Date
9/30/25
Potential Value
$161K
Federal Agency
Medical Command
Awardee
Lucigen Corporation
Ultimate Awardee
Not listed
NAICS Category
541713 - Research and Development in Nanotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78234, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the U.S. Department of the Army Medical Command (MEDCOM) to Lucigen Corporation, a foreign-owned, for-profit manufacturer of goods, in the amount of $81,556.00. The contract is for specialized laboratory services to support the Army's Whole Genome and Metagenomics Sequencing Project, including DNA isolation, whole genome sequencing, and metagenomics sequencing. The work involves constructing fragmented DNA libraries, performing DNA...
This federal contract award to Lucigen Corporation, a foreign-owned for-profit manufacturer of goods, was made by the Plains Area division of a civilian federal agency for the delivery of services related to "KLEIN-MAP PARENTAL AND F1 HYBRID RNASEQ DATA TO APPROPRIATE GENOMES". The $3,900 firm-fixed-price purchase order contract did not have a set-aside designation. Lucigen has previously received other federal contracts and grants, including for providing specialized laboratory...
<p>The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Lucigen Corporation, a foreign-owned, for-profit manufacturer of goods, for Fragment Library Service (FRAG). The contract, which was set aside for small businesses, has a potential value of $140,546.00 and a completion date of August 14, 2018. The place of performance is Middleton, WI 53562, USA.</p>
The U.S. Department of the Army's Medical Command (MEDCOM) awarded a Blanket Purchase Agreement (BPA) call order to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents, for the delivery of a SEQ 100 Sequencing System and associated supplies. The contract, valued at $60,300.26, is a firm fixed price award with no set-aside designation. Illumina has previously received prime and subcontract awards from various federal agencies, including the NIH, CDC, USDA, and VA, to provide...
This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genomic sequencing and analysis solutions. The $456,023.48 contract provides various reagents and consumables, including TruSeq Cluster Kit V3, PhiX Control V3 Kit, and TruSeq Small RNA Library Prep Kit V2, to support genomic sequencing and analysis capabilities. Illumina has a history of providing sequencing systems, reagents, and services to federal agencies such...
This firm fixed-price purchase order, valued at $2,881,079.36, was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract supports genomic sequencing and analysis needs, with Illumina providing a range of sequencing systems, reagents, and bioinformatics products. This award does not have a set-aside designation. Illumina has previously received prime contract and subcontract awards from various federal...
This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $154,828.40 contract is for the purchase of reagents to support MEDCOM's genomic analysis and sequencing capabilities. Illumina has previously received other federal contracts and subcontracts from agencies like the National Institutes of Health, Centers for Disease Control, and Department of Veterans Affairs to provide...
This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $680,732.58, is for the delivery of a MiSeq FGx Sequencing System, which supports genetic and genomic analysis. The contract has no set-aside designation. Illumina has a history of providing sequencing systems and related goods and services to various federal agencies such as the National...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and analytical instrumentation and reagents. The contract, valued at $95,931.00, is for the procurement of an SY-410-1003 ASSY, TLA, MISEQ2 item. The contract has no set-aside designation and is intended to support Illumina's provision of sequencing systems, reagents, and services to MEDCOM and its research activities. Illumina has a history of...
The Department of the Army Medical Command awarded a $247,627.76 firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturing organization, for Illumina RNA Prep with Enrichment products and services. The contract does not have a set-aside designation. This award was made without full and open competition under the sole-source authority of FAR 13.106-1(b)(1)(i) based on Illumina's proprietary sequencing technology and status as the sole manufacturer. Illumina has a history of...